Serrand C

Clinical Research Support Unit (USMR), CHU Nîmes, Univ. Montpellier, Nîmes, France.

1 preprint · 3 papers

PreprintPsilocybin

Reduced egocentricity after psilocybin in patients with alcohol use disorder: a pilot randomized controlled trial

Bukowski H, de Timary P, Belahda D +4

Europe PMC2026
ArticlePsilocybin

Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms.

Garcia Garcia M, Belahda D, Graux C +5

Europe PMC2026
ArticlePsilocybin

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial.

Luquiens A, Belahda D, Graux C +5

Europe PMC2025
ArticleKetamine

Ketamine as adjuvant treatment in eating disorders: an exploratory study of a case series and retrospective analysis.

Escobedo-Aedo PJ, Serrand C, Kabani S +1

Europe PMC2025